Apollo Tyres Ltd

- There is no mention of any current or planned fundraising through debt or equity in the transcript. - The company’s consolidated net debt stood stable at INR 26-27 billion as of September 2025 and March 2025, indicating no recent large borrowing. - Management highlights maintaining focus on profitability, free cash flow generation, and return ratios rather than raising capital. - Capex plans for FY’26 are on schedule with no changes in guidance, and no indications of requiring external fundraising for expansions. - The company is cautious about acquisitions and would consider only economically and strategically sensible deals, but no fundraise for M&A is indicated. - Overall, the call reflects a stable financial position with no announced or anticipated new debt or equity fundraises in the near term.

- PCR capacity expansion is underway in Hungary with production expected to start from the next fiscal year. - Passenger car capacity expansion is also planned in Andhra Pradesh, on schedule. - Apollo's overall Capex plan for FY'26 remains unchanged, with more details expected after next year's budget cycle. - The company is prioritizing capacity expansion in passenger car segments in both India and Europe. - No major inorganic acquisitions recently, but Apollo may consider small to medium-sized, economically and strategically sensible acquisitions in the off-highway tyre (OHT) segment. - The Enschede plant closure in Europe is expected by end of June 2026, leading to improved profitability. - Capex and investments focus on profitable growth, free cash flow generation, and return ratios.

- Q2 FY26 saw a 6% consolidated revenue growth YoY with strong domestic and export performance. - India expects continued healthy demand momentum in H2 FY26, supported by GST changes and infrastructure/mining rebounds. - Replacement demand anticipated to rise from current low levels to mid-to-high single-digit growth. - European volumes showed positive growth (4% YoY in Q2) with expectations of low single-digit growth ahead despite challenging conditions. - Exports grew in double digits in Q2; full-year export growth expected to reach high single digits. - Premiumisation efforts, particularly the Vredestein brand in India, are driving volume growth. - Capacity expansions in PCR segments (Hungary and Andhra Pradesh) are set to increase production from next fiscal year, supporting volume growth. - Overall, management is optimistic about maintaining or accelerating revenue and volume growth in both Indian and European markets for H2 FY26.

- Q3 margin expected to improve sequentially due to stable raw material costs and strong replacement demand, providing operating leverage. (Page 14) - Outlook for H2 FY26 is optimistic with expected healthy demand momentum sustained by GST rationalization, rebound in infrastructure and mining sectors, and strong October demand. (Page 6, 7) - Volume growth in India is projected to move from mid-single digits to mid-to-high single digits driven by replacement demand increase. (Page 7) - European operations growth expected to continue at low single digits with profitability to improve post-Enschede plant closure by June 2026. (Pages 5, 8) - ROCE target is to reach around 15% near-term, aiming higher than previous cycle with boost from European profitability. (Page 11) - Overall, the management expects continued profitable growth with focus on margin improvement, free cash flow, and return ratios. (Pages 4, 5, 14)

The transcript does not provide specific details on current or expected orderbook or pending orders for Apollo Tyres. However, some relevant points related to demand and operations include: - Demand outlook is positive with healthy momentum in H2 FY26 due to GST rationalisation and rebound in infrastructure and mining segments. - Replacement demand expected to move from current levels to mid-to-high single digits growth. - OEM demand shows some pickup, particularly in the truck segment; PCR OEM demand expected to improve gradually but not at high levels. - Capacity expansions underway in PCR segment in Hungary and Andhra Pradesh, with PCR expansion to come through towards end of next fiscal year. - Exports growth in double digits this quarter, aiming for high single-digit growth for the full year. - No direct commentary on orderbook or pending orders was provided in the call.